Quarterly report · Q2
3645.TEDINET S100PYWE
Period2022-06-01 → 2022-11-30
Filed2023-01-16
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥2.0bn | 2022-06-01 → 2022-11-30 | Cons. | Net sales |
| Revenue | ¥3.7bn | 2021-06-01 → 2022-05-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥1.7bn | 2021-06-01 → 2021-11-30 | Cons. | Net sales |
| Operating income | ¥192m | 2022-06-01 → 2022-11-30 | Cons. | Operating income |
| Operating income | ¥249m | 2021-06-01 → 2021-11-30 | Cons. | Operating income |
| Ordinary income | ¥220m | 2022-06-01 → 2022-11-30 | Cons. | Ordinary income |
| Ordinary income | ¥454m | 2021-06-01 → 2022-05-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥247m | 2021-06-01 → 2021-11-30 | Cons. | Ordinary income |
| Profit before tax | ¥221m | 2022-06-01 → 2022-11-30 | Cons. | Income before income taxes |
| Profit before tax | ¥329m | 2021-06-01 → 2021-11-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥131m | 2022-06-01 → 2022-11-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥385m | 2021-06-01 → 2022-05-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥247m | 2021-06-01 → 2021-11-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥144m | 2022-06-01 → 2022-11-30 | Cons. | Profit loss |
| Net income | ¥250m | 2021-06-01 → 2021-11-30 | Cons. | Profit loss |
| Total assets | ¥3.4bn | at 2022-11-30 | Cons. | Assets |
| Total assets | ¥3.2bn | at 2022-05-31 | Cons. | Assets |
| Total assets | ¥2.6bn | at 2021-11-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥1.5bn | at 2022-11-30 | Cons. | Liabilities |
| Total liabilities | ¥1.4bn | at 2022-05-31 | Cons. | Liabilities |
| Net assets / equity | ¥2.0bn | at 2022-11-30 | Cons. | Net assets |
| Net assets / equity | ¥1.7bn | at 2022-05-31 | Cons. | Net assets |
| Net assets / equity | ¥1.6bn | at 2021-11-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.2bn | at 2022-11-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.1bn | at 2022-05-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.2bn | at 2022-11-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.1bn | at 2022-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥951m | at 2021-11-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥869m | at 2021-05-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥59m | 2022-06-01 → 2022-11-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥343m | 2021-06-01 → 2022-05-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥85m | 2021-06-01 → 2021-11-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥32m | 2022-06-01 → 2022-11-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥355m | 2021-06-01 → 2022-05-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥68m | 2021-06-01 → 2021-11-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥906,000 | 2022-06-01 → 2022-11-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥282m | 2021-06-01 → 2022-05-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥70m | 2021-06-01 → 2021-11-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥14.74 | 2022-06-01 → 2022-11-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥8.19 | 2022-09-01 → 2022-11-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥43.98 | 2021-06-01 → 2022-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥28.42 | 2021-06-01 → 2021-11-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥11.39 | 2021-09-01 → 2021-11-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 56.0% | at 2022-11-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 54.1% | at 2022-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 60.3% | at 2021-11-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 45
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-06-01 → 2022-11-30 | ¥2m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-06-01 → 2022-11-30 | ¥2m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-06-01 → 2022-11-30 | ¥2m |
| jpcrp040300-q2r_E24982-000Mediaplatformreportable segment | revenue | 2022-06-01 → 2022-11-30 | ¥499m |
| jpcrp040300-q2r_E24982-000Mediaplatformreportable segment | revenue external | 2022-06-01 → 2022-11-30 | ¥499m |
| jpcrp040300-q2r_E24982-000Mediaplatformreportable segment | revenue intersegment | 2022-06-01 → 2022-11-30 | ¥2,000 |
| jpcrp040300-q2r_E24982-000Mediaplatformreportable segment | segment profit | 2022-06-01 → 2022-11-30 | ¥297m |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | revenue | 2022-06-01 → 2022-11-30 | ¥83m |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | revenue external | 2022-06-01 → 2022-11-30 | ¥83m |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | revenue intersegment | 2022-06-01 → 2022-11-30 | ¥12,000 |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | segment profit | 2022-06-01 → 2022-11-30 | ¥25m |
| jpcrp040300-q2r_E24982-000Medical Institution Management Supportreportable segment | revenue | 2022-06-01 → 2022-11-30 | ¥1.4bn |
| jpcrp040300-q2r_E24982-000Medical Institution Management Supportreportable segment | revenue external | 2022-06-01 → 2022-11-30 | ¥1.4bn |
| jpcrp040300-q2r_E24982-000Medical Institution Management Supportreportable segment | revenue intersegment | 2022-06-01 → 2022-11-30 | ¥213,000 |
| jpcrp040300-q2r_E24982-000Medical Institution Management Supportreportable segment | segment profit | 2022-06-01 → 2022-11-30 | ¥66m |
| —segment total | revenue | 2022-06-01 → 2022-11-30 | ¥2.0bn |
| —segment total | revenue external | 2022-06-01 → 2022-11-30 | ¥2.0bn |
| —segment total | revenue intersegment | 2022-06-01 → 2022-11-30 | ¥228,000 |
| —segment total | segment profit | 2022-06-01 → 2022-11-30 | ¥389m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-06-01 → 2022-11-30 | ¥2.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-06-01 → 2022-11-30 | ¥2.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-06-01 → 2022-11-30 | ¥228,000 |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-06-01 → 2022-11-30 | ¥390m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-06-01 → 2021-11-30 | ¥2m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-06-01 → 2021-11-30 | ¥2m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-06-01 → 2021-11-30 | ¥2m |
| jpcrp040300-q2r_E24982-000Mediaplatformreportable segment | revenue | 2021-06-01 → 2021-11-30 | ¥483m |
| jpcrp040300-q2r_E24982-000Mediaplatformreportable segment | revenue external | 2021-06-01 → 2021-11-30 | ¥483m |
| jpcrp040300-q2r_E24982-000Mediaplatformreportable segment | segment profit | 2021-06-01 → 2021-11-30 | ¥326m |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | revenue | 2021-06-01 → 2021-11-30 | ¥76m |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | revenue external | 2021-06-01 → 2021-11-30 | ¥76m |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | revenue intersegment | 2021-06-01 → 2021-11-30 | ¥8,000 |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | segment profit | 2021-06-01 → 2021-11-30 | ¥32m |
| jpcrp040300-q2r_E24982-000Medical Institution Management Supportreportable segment | revenue | 2021-06-01 → 2021-11-30 | ¥1.1bn |
| jpcrp040300-q2r_E24982-000Medical Institution Management Supportreportable segment | revenue external | 2021-06-01 → 2021-11-30 | ¥1.1bn |
| jpcrp040300-q2r_E24982-000Medical Institution Management Supportreportable segment | revenue intersegment | 2021-06-01 → 2021-11-30 | ¥19,000 |
| jpcrp040300-q2r_E24982-000Medical Institution Management Supportreportable segment | segment profit | 2021-06-01 → 2021-11-30 | ¥77m |
| —segment total | revenue | 2021-06-01 → 2021-11-30 | ¥1.7bn |
| —segment total | revenue external | 2021-06-01 → 2021-11-30 | ¥1.7bn |
| —segment total | revenue intersegment | 2021-06-01 → 2021-11-30 | ¥28,000 |
| —segment total | segment profit | 2021-06-01 → 2021-11-30 | ¥436m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-06-01 → 2021-11-30 | ¥1.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-06-01 → 2021-11-30 | ¥1.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-06-01 → 2021-11-30 | ¥28,000 |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-06-01 → 2021-11-30 | ¥437m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 492
| Item | Context | Value | Unit |
|---|---|---|---|
| Purchase of insurance funds inv cf | Prior1YTDDuration | -860000 | JPY |
| Purchase of insurance funds inv cf | CurrentYTDDuration | -860000 | JPY |
| Other net inv cf | Prior1YTDDuration | -1320000 | JPY |
| Other net inv cf | CurrentYTDDuration | -642000 | JPY |
| Net cash provided by used in investment activities | Prior1YTDDuration | 68499000 | JPY |
| Net cash provided by used in investment activities | CurrentYTDDuration | -32156000 | JPY |
| Net increase decrease in short term loans payable fin cf | Prior1YTDDuration | 10000000 | JPY |
| Net increase decrease in short term loans payable fin cf | CurrentYTDDuration | 50367000 | JPY |
| Repayment of long term loans payable fin cf | Prior1YTDDuration | -45671000 | JPY |
| Repayment of long term loans payable fin cf | CurrentYTDDuration | -16232000 | JPY |
| Cash dividends paid fin cf | Prior1YTDDuration | -34193000 | JPY |
| Cash dividends paid fin cf | CurrentYTDDuration | -35041000 | JPY |
| Net cash provided by used in financing activities | Prior1YTDDuration | -69864000 | JPY |
| Net cash provided by used in financing activities | CurrentYTDDuration | -906000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | Prior1YTDDuration | -1284000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | CurrentYTDDuration | 13543000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1YTDDuration | 82247000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYTDDuration | 39925000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 868661000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 1128788000 | JPY |
| Cash and cash equivalents | Prior1QuarterInstant | 950908000 | JPY |
| Cash and cash equivalents | CurrentQuarterInstant | 1168714000 | JPY |
| Directors compensations sga | Prior1YTDDuration | 71087000 | JPY |
| Directors compensations sga | CurrentYTDDuration | 76883000 | JPY |
| Salaries and allowances sga | Prior1YTDDuration | 147994000 | JPY |
| Salaries and allowances sga | CurrentYTDDuration | 214734000 | JPY |
| Advertising expenses sga | Prior1YTDDuration | 31031000 | JPY |
| Advertising expenses sga | CurrentYTDDuration | 52160000 | JPY |
| Provision of allowance for doubtful accounts sga | Prior1YTDDuration | -2000 | JPY |
| Provision of allowance for doubtful accounts sga | CurrentYTDDuration | -3428000 | JPY |
| Provision for bonuses sga | Prior1YTDDuration | 2185000 | JPY |
| Provision for bonuses sga | CurrentYTDDuration | 1009000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E24982-000MediaplatformReportableSegmentsMember | 483433000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E24982-000MedicalInstitutionManagementSupportReportableSegmentsMember | 1141179000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E24982-000MedicalBToBReportableSegmentsMember | 75650000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReportableSegmentsMember | 1700264000 | JPY |
| Revenues from external customers | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 1809000 | JPY |
| Revenues from external customers | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 1702073000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E24982-000MediaplatformReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E24982-000MedicalInstitutionManagementSupportReportableSegmentsMember | 19000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E24982-000MedicalBToBReportableSegmentsMember | 8000 | JPY |
| Transactions with other segments | Prior1YTDDuration_ReportableSegmentsMember | 28000 | JPY |
| Transactions with other segments | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 28000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E24982-000MediaplatformReportableSegmentsMember | 483433000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E24982-000MedicalInstitutionManagementSupportReportableSegmentsMember | 1141199000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E24982-000MedicalBToBReportableSegmentsMember | 75659000 | JPY |
| Net sales | Prior1YTDDuration_ReportableSegmentsMember | 1700292000 | JPY |
| Net sales | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 1809000 | JPY |
| Net sales | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 1702102000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |